Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours; After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours; After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours; After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours; After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours; After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours; This spontaneous case was reported by a patient and describes the occurrence of the first episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours), the first episode of MYALGIA (After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours), the second episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours), the second episode of MYALGIA (After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours) and the third episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A, 031A21A and 071F21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (to a lot of medications (might be 15 medications), like Isosorbide), Type II diabetes mellitus (under control), Osteoarthritis (under control), Cholesterol (under control) and Blood pressure high (under control). Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) for Type II diabetes mellitus.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced the first episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours) and the first episode of MYALGIA (After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours). On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced the second episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours) and the second episode of MYALGIA (After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours). On 05-Nov-2021, the patient experienced the third episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours) and the third episode of MYALGIA (After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Nov-2021, last episode of PYREXIA (After 1st and 2nd dose patient felt fever during 24 hours/After 1st booster she experienced same symptoms during 12 hours) had resolved. On 15-Nov-2021, last episode of MYALGIA (After 1st and 2nd dose patient felt body aches during 24 hours/After 1st booster she experienced same symptoms during 12 hours) had resolved.            The patient did not receive other vaccines given within 1 month prior to Moderna COVID-19 vaccine.   Patient stated she was under regular medications but there were like 7 medications, and she only provided 1 name.  It was reported that, after 1st and 2nd dose patient felt fever and body aches for 24 hours. After 1st booster she experienced same symptoms for 12 hours.  No treatment medications were reported.   This case was linked to MOD-2022-648663 (Patient Link).